|
Virizuela JA, Carratalà J, Aguado JM, Vicente D, Salavert M, Ruiz M, Ruiz I, Marco F, Lizasoain M, Jiménez-Fonseca P, Gudiol C, Cassinello J, Carmona-Bayonas A, Aguilar M, Cruz JJ. Management of infection and febrile neutropenia in patients with solid cancer. Clin Transl Oncol. 2016 Jun;18(6):557-70. doi: 10.1007/s12094-015-1442-4. Epub 2015 Nov 17. PubMed PMID: 26577106.
AÑO: 2016; IF: 2.353
|
26577106
|
Jiménez-Fonseca P, Carmona-Bayonas A, Martín-Pérez E, Crespo G, Serrano R, Llanos M, Villabona C, García-Carbonero R, Aller J, Capdevila J, Grande E; Spanish Neuroendocrine Tumor Group (GETNE).. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev. 2015 Sep;34(3):381-400. doi: 10.1007/s10555-015-9573-1. Review. PubMed PMID: 26245646.
AÑO: 2015; IF: 5.316
|
|
Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, Antonio M, Font C, Biosca M, Ramchandani A, Martínez J, Hernando Cubero J, Espinosa J, Martínez de Castro E, Ghanem I, Beato C, Blasco A, Garrido M, Bonilla Y, Mondéjar R, Arcusa Lanza MÁ, Aragón Manrique I, Manzano A, Sevillano E, Castañón E, Cardona M, Gallardo Martín E, Pérez Armillas Q, Sánchez Lasheras F, Ayala de la Peña F. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347. PubMed PMID: 25559804.
AÑO: 2015; IF: 20.982
|
|
Font C, Carmona-Bayonas A, Plasencia JM, Calvo-Temprano D, Sánchez M, Jiménez-Fonseca P, Beato C, Biosca M, Vicente V, Otero R; en representación de los Investigadores del Proyecto EPIPHANY.. [Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study]. Med Clin (Barc). 2015 Jan;144 Suppl 1:31-7. doi: 10.1016/S0025-7753(15)30016-6. Spanish. PubMed PMID: 25771090.
AÑO: 2015; IF: 1.267
|
|
Urrego EG, Carmona-Bayonas A, González-Billalabeitia E, Ayala de la Peña F. Should anticoagulation therapy be withheld in patients with active cancer after 6 months of low-molecular weight heparin? J Clin Oncol. 2015 May 20;33(15):1713. doi: 10.1200/JCO.2014.60.6384. PubMed PMID: 25870093.
AÑO: 2015; IF: 20.982
|